NCT01877005 A Phase II Study of Oral JAK1/JAK2 Inhibitor INC424 in Adult Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT01871311 A Phase I Study of Nilontinib and Cetuximab in Patients With Solid Tumors Status TERMINATED Phase PHASE1
NCT01867021 Immunogenicity, Safety and Tolerability of a Trivalent Subunit Inactivated Vaccine in Healthy Subjects 50 Years and Above Status COMPLETED Phase PHASE4
NCT01862965 Treatment of Newly Diagnosed Moderate or Severe Chronic Graft-versus-host Disease With Prednisone and Everolimus Status COMPLETED Phase PHASE2
NCT01856101 Study of BEZ235 as Monotherapy in Patients With Transitional Cell Carcinoma After Failure of Platinum Based Chemotherapy Status TERMINATED Phase PHASE2
NCT01848145 Rapid Infusion of Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE2
NCT01832259 A Study of VEGF Tyrosine Kinase Inhibitor (Pazopanib) in Men With High-Risk Prostate Cancer Followed by Radical Prostatectomy and Pelvic Lymph Node Dissection Status COMPLETED Phase PHASE2
NCT01827930 Phase III Trial Evaluating the Effectiveness of a Dose Adjustment of Imatinib Mesylate on the Molecular Response Status TERMINATED Phase PHASE3
NCT01822483 A Prospective Study to Investigate Mycophenolic Acid (MPA) Exposure Through Area Under the Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) and After Conversion to Mycophenolate Sodium (EC-MPS) Status COMPLETED Phase PHASE4
NCT01811290 A Pilot Study Assessing the Impact of Gilenya Therapy on Bone Density Change in Relapsing Forms of Multiple Sclerosis Status UNKNOWN Phase N/A
NCT01810042 Indocyanine Angiographic Changes of Choroidal Neovascularization by Ranibizumab Status COMPLETED Phase PHASE4
NCT01806610 Study of Safety and Tolerability of BPS804 in Patients With Late-stage Chronic Kidney Disease Status WITHDRAWN Phase PHASE2
NCT01803763 Prospective Double-blind Placebo-controlled Study of the Effect of Xolair (Omalizumab) in Chronic Urticaria Patients Status COMPLETED Phase PHASE2/PHASE3
NCT01799486 Telbivudine Renoprotective Effect in Patients With the HBV-related Liver Cirrhosis: a Randomized Controlled Trial Status UNKNOWN Phase PHASE4
NCT01797523 A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01797120 Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI Status COMPLETED Phase PHASE2
NCT01796639 Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China Status COMPLETED Phase N/A